Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads

Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads

Abstract The safety and efficacy of drug-eluting beads transarterial chemoembolization (DEB-TACE) for unresectable renal cell carcinoma (RCC) still unknown. We aimed to assess the feasibility, safety and clinical efficacy of DEB-TACE with doxorubicin-loaded CalliSpheres beads (CB) in patients with u...

Full description

Bibliographic Details
Main Authors:	Yonghua Bi, Xiaonan Shi, Jianzhuang Ren, Mengfei Yi, Xinwei Han
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-12334-x

Similar Items

Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma
by: Yonghua Bi, et al.
Published: (2021-05-01)

Clinical evaluation of oxaliplatin-loaded drug-eluting callispheres beads transarterial chemoembolization for unresectable or recurrent esophageal carcinoma
by: Yonghua Bi, et al.
Published: (2024-10-01)

Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022-08-01)

A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma
by: Xiaonan Shi, et al.
Published: (2023-11-01)

Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis
by: Yonghua Bi, et al.
Published: (2022-07-01)

5-Fluorouracil combined with CalliSphere drug-eluting beads or conventional transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score weighting analysis
by: Min Wei, et al.
Published: (2024-10-01)

Comparison of CalliSpheres® microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial
by: Shi Zhongxing, et al.
Published: (2023-02-01)

Efficacy and safety of raltitrexed-eluting CalliSpheres bead transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma: a single-arm, prospective study
by: Zhanguo Sun, et al.
Published: (2024-02-01)

Efficacy and safety of transarterial chemoembolization with CalliSpheres® Microspheres in head and neck cancer
by: Fei Gao, et al.
Published: (2022-08-01)

CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study
by: Baolin Wu, et al.
Published: (2018-03-01)

Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022-01-01)

The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer
by: Yonghua Bi, et al.
Published: (2022-11-01)

Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
by: Xuhua Duan, et al.
Published: (2022-01-01)

CalliSpheres® drug-eluting beads trans-bronchial artery chemoembolization in treatment of advanced primary lung cancer with massive hemoptysis
by: LIU Song, et al.
Published: (2023-06-01)

Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients
by: Ning Peng, et al.
Published: (2022-08-01)

Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
by: Bin Liang, et al.
Published: (2021-03-01)

Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis
by: Haitao Li, et al.
Published: (2023-10-01)

Early changes in peripheral blood cytokine levels after the treatment of metastatic hepatic carcinoma with CalliSpheres microspheres drug-eluting beads transcatheter arterial chemoembolization
by: Ying Liu, et al.
Published: (2022-07-01)

Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer
by: Wenhui Wang, et al.
Published: (2022-09-01)

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial
by: Xuhua Duan, et al.
Published: (2024-11-01)

Optimized Loading of Idarubicin in CalliSpheres<sup>®</sup> Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties
by: Enhao Lu, et al.
Published: (2021-05-01)

CalliSpheres® microsphere transarterial chemoembolization combined with 125I brachytherapy for patients with non–small‐cell lung cancer liver metastases
by: Guangsheng Zhao, et al.
Published: (2022-08-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
by: Su Jong Yu, et al.
Published: (2023-03-01)

Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma
by: Haitao Liu, et al.
Published: (2023-05-01)

Efficacy and safety of CalliSpheres drug-eluting bead bronchial arterial infusion chemoembolization vs. bland embolization in advanced lung cancer with hemoptysis: A multicenter retrospective study
by: Song Liu, et al.
Published: (2024-11-01)

Tirapazamine-loaded CalliSpheres microspheres: Preparation and characterization as a chemoembolization agent for liver cancer
by: Xin Zhang, et al.
Published: (2023-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
by: Yanqiao Ren, et al.
Published: (2022-03-01)

Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study
by: Liang B, et al.
Published: (2020-02-01)

Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: A case series study
by: Yonghua Bi, et al.
Published: (2022-09-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Efficacy and safety of CalliSpheres drug-eluting beads for bronchial arterial chemoembolization for refractory non-small-cell lung cancer and its impact on quality of life: A multicenter prospective study
by: Yu Wei Zhao, et al.
Published: (2023-04-01)

Pingyangmycin-loaded drug-eluting beads transarterial embolisation for giant cavernous haemangioma of the liver: A case report
by: Yonghua Bi, et al.
Published: (2024-08-01)

Hepatic Arterial Chemoembolization With Arsenic Trioxide Eluting CalliSpheres Microspheres Versus Lipiodol Emulsion: Pharmacokinetics And Intratumoral Concentration In A Rabbit Liver Tumor Model
by: Duan X, et al.
Published: (2019-11-01)

Bevacizumab-loaded CalliSpheres beads: in vitro loading, release profiles and application in rabbit liver VX2 tumor model
by: Kewei Ren, et al.
Published: (2023-07-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

One-step fabrication of lidocaine/CalliSpheres® composites for painless transcatheter arterial embolization
by: Chuan Tian, et al.
Published: (2022-10-01)

Clinical effect of bronchial arterial infusion chemotherapy and CalliSpheres drug‐eluting beads in patients with stage II–IV lung cancer: A prospective cohort study
by: Bin Shang, et al.
Published: (2020-08-01)

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
by: Hao Li, et al.
Published: (2023-12-01)

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma
by: Chiu SH, et al.
Published: (2020-11-01)

Evaluation of a new beads reflux control microcatheter in drug-eluting bead transarterial chemoembolization
by: Youssef Zaarour, et al.
Published: (2024-06-01)